We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Maintenance Therapy With Histamine Dihydrochloride and Interleukin-2 in Adult Acute Myeloid Leukemia (AML) Patients With Measurable Minimal Residual Disease (MRD)- a Non-interventional Study (NIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01770158
Recruitment Status : Unknown
Verified January 2013 by Jochen Greiner, University of Ulm.
Recruitment status was:  Recruiting
First Posted : January 17, 2013
Last Update Posted : January 17, 2013
Information provided by (Responsible Party):
Jochen Greiner, University of Ulm

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : March 2016
  Estimated Study Completion Date : March 2016